Crypto EcoBlog
Thermo Fisher launched an $11.59 billion bid for genetic testing company Qiagen NV. This acquisition may create a powerhouse that could be the next big thing in the biomedical field.Thermo Fisher Scientific Inc (NYSE: TMO) seems set to acquire Qiagen NV (NYSE: QGEN). The deal is reportedly worth about $11.59 billion. With its headquarters in the Netherlands, Qiagen runs operations from Germany. Sources indicate that the deal is expected to be rounded up as early as this week. After talks...
Read More »